# Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

> **NCT01682746** · PHASE1 · COMPLETED · sponsor: **Harry T Whelan, MD** · enrollment: 5 (actual)

## Conditions studied

- Brain Tumor, Recurrent

## Interventions

- **DRUG:** Photofrin (porfimer sodium) & photodynamic therapy.

## Key facts

- **NCT ID:** NCT01682746
- **Lead sponsor:** Harry T Whelan, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2018-06-29
- **Final completion:** 2018-06-29
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01682746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01682746, "Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01682746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*